+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


In-depth Analysis - CRISPR/Cas9 Technology

  • ID: 4599615
  • Report
  • January 2018
  • Region: Global
  • 120 pages
  • Ingenious e-Brain Solutions
1 of 3
The report studies the analysis and multidimensional technical categorization viz. filing trends, country wise etc.

Technology forecast & core technology visualizations, prosecution visualization, statistical analytics, citation & classification visualization etc.

Comprehensive list of players (companies & research institute), emerging players, cross domain companies & inventor visualizations.

White space analysis, competitor bench marking

CRISPR: Strategic Analysis SWOT & PEST

CRISPR-Cas system-based genome editing global market over the forecast period 2016- 2025

CRISPR market segmentation by region, application, end user & product.

Industry movement partnerships, agreements, collaborations, expansions, acquisitions, and product & service launches in the market

Profiles of prominent companies along with their market share & product portfolio

Recent advances & development

The report studies CRISPR Technology in various below stated segments:
By Application
  • Agrisciences
  • Cellular & animal study
  • Food & Nutrition
  • Therapeutics
  • Detection/Diagnosis
  • Veterinary
By End User
  • Biotechnology & Pharma firms
  • Research Institutes
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Due to current updates on this product, the delivery time may be extended to up to 15 business days.
Note: Product cover images may vary from those shown
2 of 3
1.Technology Overview
1.2.Executive Summary
1.3.Technical Taxonomy

2.Technology Insights
2.1.Systems and/or Host Organism
2.1.1. Prokaryotes
2.1.2. Eukaryotes
2.2.Target Gene
2.3.CRISPR in Agrisciences
2.3.1. CRISPR in plant biomass production
2.3.2. CRISPR in stress tolerance
2.3.3. CRISPR in phenotype modification
2.3.4. CRISPR in fertility
2.3.5. Other CRISPR mediated modification in plants
2.4.CRISPR in Veterinary
2.4.1. CRISPR in livestock diseases
2.4.2. CRISPR in livestock growth/breeding
2.4.3. CRISPR in controlling livestock sexual maturity
2.4.4. CRISPR in livestock related material production
2.4.5. Other CRISPR mediated livestock modification
2.5.CRISPR in Therapeutics
2.5.1. CRISPR mediated therapy in different diseases CRISPR in oncology CRISPR in autoimmune diseases CRISPR in infectious diseases
2.5.2. CRISPR based trials
2.5.3. CRISPR in diagnosis/prognosis
2.6.CRISPR in Cellular and Animal Studies
2.6.1. CRISPR modified cell lines/primary cells
2.6.2. CRISPR modified animal models
2.7.CRISPR in Food and Nutrition
2.7.1. Genotyping of bacteria
2.7.2. Keeping perishables fresher for longer time
2.7.3. Improving flavor
2.7.4. CRISPR-Cas for enhanced meat production
2.8.CRISPR based kits
2.9.CRISPR based modification for biofuel production
2.10.CRISPR based other modifications (basic science)

3. Landscape Overview
3.1.Year wise technology filing trend
3.2.Top Players
3.2.1.Year wise filing trend of top players
3.2.2.Top institutes
3.2.3.Top company’s
3.2.4.Company vs Institute
3.3.Top IPC/CPC Classifications
3.4.Geographic Activity
3.4.1.Geographically filing activity
3.4.2.Top company’s geographically
3.4.3.Top institutes geographically
3.4.4.Company vs Institute
3.5.Top Players
3.5.1.Filing Trends
3.5.2.Top Inventors
3.5.3.Jurisdictions of deposition Country
3.6.New Entrants
3.6.1.Filing Trends
3.6.2.Top Inventors
3.6.3.Jurisdictions of deposition Country
3.7.Collaborations / Acquisitions / Licensing Activity
3.7.1.Collaboration between companies
3.7.2.Collaboration between company and universities
3.7.3.Licensing activity
3.7.4.Acquisition in the technology domain
3.8.Technology based comparison between top players

4.Research Literature Overview
4.1.Year wise publication trend
4.1.1.Top Authors
4.1.2.Top Companies
4.1.3.Top Universities
4.2.Technology Breakdown
4.2.1.Non- distribution in technical aspects

5.Recent in CRISPR viz. CRISPR/Cpf1, xCas9 etc.

6.White Space Analysis

7.Future of CRISPR

8.Press releases
8.1.Contract / funding information
8.1.1.Contract / funding objective
8.1.2.Contract / funding information
8.2.Partnership / Collaboration / Licensing
8.2.1.Partnership / Collaboration / Licensing objective
8.2.2.Information of associated companies
8.3.New emerging technologies
8.3.1.Information of associated company
8.3.2.Information of associated inventors
8.4.Undergoing research activities
8.4.1.Information of associated company
8.4.2.Information of associated inventors

9.Conference Updates
9.1.Technology Opinions from Experts
9.1.1.Industry expert’s opinion of the developments
9.2.Technology Collaboration Insights
9.3.Strategies of Companies working in the Domain
9.4.Investor Details
9.5.Recent Product Developments
9.5.1.Product overview
9.5.2.Company information
9.5.3.Information of associated team
9.6.Research Technology Updates
9.6.1.Technology overview
9.6.2.Information of associated team

10.CRISPR: Market Overview
10.1 CRISPR Market Segmentation-By Region
10.1.1 CRISPR Market Segmentation-North America
10.1.2 CRISPR Market Segmentation-Europe
10.1.3 CRISPR Market Segmentation-Asia Pacific
10.2 CRISPR Market Segmentation-By Application
10.3 CRISPR Market Segmentation-End Use
10.4 CRISPR Market segmentation-By Product

11.CRISPR- Market Determinants

12.CRISPR-Opportunity Vs. Restraints

13.CRISPR: Strategic Analysis SWOT & PEST

14.CRISPR Market Development (2012-2017)
Note: Product cover images may vary from those shown
3 of 3